Eduard Ling
- Microbiology top 5%
- Bacterial Infections and Vaccines 7
-
- Immune Response and Inflammation 4
-
- Pneumonia and Respiratory Infections 7
-
- Autoimmune and Inflammatory Disorders Research 4
-
- Streptococcal Infections and Treatments 3
-
- Genetic factors in colorectal cancer 3
-
- Colorectal Cancer Treatments and Studies 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Ron DaganMaxim PortnoiJerry M. WellsKarin OverwegVered Chalifa‐CaspiFrancis MulhollandNoga Givon‐LaviDaniel Benharroch
- Cited by
- MicrobiologyImmunologyEpidemiology
- Journals
- Anticancer Research (3 papers)Clinical & Experimental Immunology (3 papers)Lara D. Veeken (2 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Eduard Ling
26 papers receiving 547 citations
Peers
Comparison fields: 5 of 83
- Microbiology 113
- Immunology 159
- Epidemiology 196
- Hematology 46
- Endocrinology 20
Countries citing papers authored by Eduard Ling
This map shows the geographic impact of Eduard Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Ling more than expected).
Fields of papers citing papers by Eduard Ling
This network shows the impact of papers produced by Eduard Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Ling. The network helps show where Eduard Ling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eduard Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 0 | |
| 8 | 2019 | 0 | |
| 9 | 2018 | 9 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 24 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 8 | |
| 14 | 2014 | 10 | |
| 15 | Outcome of patients with rheumatoid arthritis: cross-sectional study of a single-center real-world inception cohort. | 2013 | 5 |
| 16 | 2008 | 76 | |
| 17 | 2006 | 21 | |
| 18 | 2005 | 20 | |
| 19 | 2004 | 31 | |
| 20 | Detection of tumor mutant APC DNA in plasma of patients with sporadic colorectal cancer. | 2000 | 10 |
About Eduard Ling
Eduard Ling is a scholar working on Microbiology, Hematology, Immunology, Transplantation and Genetics, having authored 31 papers that have together received 572 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (7 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Immune Response and Inflammation (4 papers), Streptococcal Infections and Treatments (3 papers), Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Microbiology (113 citations), Immunology (159 citations), Epidemiology (196 citations), Hematology (46 citations) and Endocrinology (20 citations). Eduard Ling has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Ron Dagan, Maxim Portnoi, Jerry M. Wells, Karin Overweg, Vered Chalifa‐Caspi, Francis Mulholland, Noga Givon‐Lavi, Daniel Benharroch, Yaffa Mizrachi Nebenzahl and Juan Lechago. Their work appears in journals such as Anticancer Research, Clinical & Experimental Immunology, Lara D. Veeken, The Journal of Rheumatology and Nanoscale Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.